FFA
KYNB

Farther Finance Advisors’s Kyntra Bio KYNB Stock Holding History

Farther Finance Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-66
Closed -$1.27K – 4045
2024
Q2 		$1.27K Hold
66
– – ﹤0.01% 2978
2024
Q1 		$3.91K Buy
+66
New +$2.84K ﹤0.01% 2178

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Farther Finance Advisors's KYNB Position: Q3 2024 in Review

Farther Finance Advisors sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 66 shares — an estimated $1.27K sold.

Farther Finance Advisors first reported a position in KYNB in Q1 2024 and held it in 2 quarters. The position peaked at $3.91K in Q1 2024. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Farther Finance Advisors reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 66 Kyntra Bio shares in Q3 2024, an estimated $1.27K.
  • Farther Finance Advisors first reported a position in Kyntra Bio in Q1 2024 and held it in 2 quarters.
  • Farther Finance Advisors's Kyntra Bio position peaked at $3.91K in Q1 2024.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Farther Finance Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.